Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Griessinger CM"'
Autor:
Poxleitner, M, Hoffmann, SH, Maurer, A, Reischl, G, Wild, AM, Griessinger, CM, Wiehr, S, Pichler, BJ, Maier, FC
Publikováno v:
Nuklearmedizin. Nuclear medicine; March 2019, Vol. 58 Issue: 2
CD147 a direct target of miR-146a supports energy metabolism and promotes tumor growth in ALK+ ALCL.
Autor:
Montes-Mojarro IA; Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard-Karls-University, Tübingen, Germany., Steinhilber J; Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard-Karls-University, Tübingen, Germany., Griessinger CM; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard-Karls-University, Tübingen, Germany., Rau A; Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard-Karls-University, Tübingen, Germany., Gersmann AK; Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard-Karls-University, Tübingen, Germany., Kohlhofer U; Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard-Karls-University, Tübingen, Germany., Fallier-Becker P; Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard-Karls-University, Tübingen, Germany., Liang HC; Department of Pathology, Unit of Experimental and Laboratory Animal Pathology, Medical University of Vienna, Vienna, Austria., Hofmann U; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; Eberhard-Karls-University, Tübingen, Germany., Haag M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; Eberhard-Karls-University, Tübingen, Germany., Klapper W; Hematopathology Section, University Hospital Schleswig-Holstein Campus Kiel/Christian-Albrechts University Kiel, Kiel, Germany., Schaeffeler E; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; Eberhard-Karls-University, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-guided and Functionally Instructed Tumor Therapies', Eberhard-Karls-University, Tübingen, Germany., Pichler BJ; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard-Karls-University, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-guided and Functionally Instructed Tumor Therapies', Eberhard-Karls-University, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany., Schwab M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; Eberhard-Karls-University, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-guided and Functionally Instructed Tumor Therapies', Eberhard-Karls-University, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.; Departments of Clinical Pharmacology, Pharmacy and Biochemistry, Eberhard-Karls-University, Tübingen, Germany., Fend F; Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard-Karls-University, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany., Bonzheim I; Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard-Karls-University, Tübingen, Germany. Irina.Bonzheim@med.uni-tuebingen.de.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany. Irina.Bonzheim@med.uni-tuebingen.de., Quintanilla-Martinez L; Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard-Karls-University, Tübingen, Germany. Leticia.Quintanilla-Fend@med.uni-tuebingen.de.; Cluster of Excellence iFIT (EXC2180) 'Image-guided and Functionally Instructed Tumor Therapies', Eberhard-Karls-University, Tübingen, Germany. Leticia.Quintanilla-Fend@med.uni-tuebingen.de.
Publikováno v:
Leukemia [Leukemia] 2022 Aug; Vol. 36 (8), pp. 2050-2063. Date of Electronic Publication: 2022 Jun 08.
Autor:
Barca C; European Institute for Molecular Imaging, University of Münster, D-48149 Münster, Germany., Griessinger CM; Roche Innovation Center, Early Clinical Development Oncology, Roche Pharmaceutical Research and Early Development, CH-4070 Basel, Switzerland., Faust A; European Institute for Molecular Imaging, University of Münster, D-48149 Münster, Germany.; Department of Nuclear Medicine, University Hospital Münster, D-48149 Münster, Germany., Depke D; European Institute for Molecular Imaging, University of Münster, D-48149 Münster, Germany., Essler M; Department of Nuclear Medicine, University Hospital Bonn, D-53127 Bonn, Germany., Windhorst AD; Department Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands., Devoogdt N; In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, B-1090 Brussel, Belgium., Brindle KM; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 ORE, UK., Schäfers M; European Institute for Molecular Imaging, University of Münster, D-48149 Münster, Germany.; Department of Nuclear Medicine, University Hospital Münster, D-48149 Münster, Germany., Zinnhardt B; European Institute for Molecular Imaging, University of Münster, D-48149 Münster, Germany.; Department of Nuclear Medicine, University Hospital Münster, D-48149 Münster, Germany.; Biomarkers and Translational Technologies, Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland., Jacobs AH; European Institute for Molecular Imaging, University of Münster, D-48149 Münster, Germany.; Department of Geriatrics and Neurology, Johanniter Hospital, D-53113 Bonn, Germany.; Centre of Integrated Oncology, University Hospital Bonn, D-53127 Bonn, Germany.
Publikováno v:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2021 Dec 22; Vol. 15 (1). Date of Electronic Publication: 2021 Dec 22.
Autor:
Sonanini D; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Germany.; Department of Medical Oncology and Pneumology, Internal Medicine VIII, Eberhard Karls University Tuebingen, Germany., Griessinger CM; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Germany., Schörg BF; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Germany., Knopf P; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Germany., Dittmann K; Division of Radiobiology and Molecular Environmental Research, Department of Radiation Oncology, Eberhard Karls University Tuebingen, Germany., Röcken M; Department of Dermatology, Eberhard Karls University Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tuebingen, Germany., Pichler BJ; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tuebingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Kneilling M; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Germany.; Department of Dermatology, Eberhard Karls University Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tuebingen, Germany.
Publikováno v:
Theranostics [Theranostics] 2021 Jun 16; Vol. 11 (16), pp. 7700-7714. Date of Electronic Publication: 2021 Jun 16 (Print Publication: 2021).
Autor:
Griessinger CM; Early Clinical Development Oncology, Roche Pharmaceutical Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland. jean.tessier@roche.com christoph_michael.griessinger@roche.com., Olafsen T; ImaginAb Inc., Inglewood, California., Mascioni A; ImaginAb Inc., Inglewood, California., Jiang ZK; ImaginAb Inc., Inglewood, California., Zamilpa C; ImaginAb Inc., Inglewood, California., Jia F; ImaginAb Inc., Inglewood, California., Torgov M; ImaginAb Inc., Inglewood, California., Romero JM; ImaginAb Inc., Inglewood, California., Marchioni F; ImaginAb Inc., Inglewood, California., Satpayev D; ImaginAb Inc., Inglewood, California., Lee C; ImaginAb Inc., Inglewood, California., Zhang G; ImaginAb Inc., Inglewood, California., Nayak TK; Early Clinical Development Oncology, Roche Pharmaceutical Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Pincha M; Roche Pharmaceutical Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Amann M; Roche Pharmaceutical Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Mohan PLB; Roche Pharmaceutical Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Richard M; Roche Pharmaceutical Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Nicolini VG; Roche Pharmaceutical Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Sam J; Roche Pharmaceutical Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Claus C; Roche Pharmaceutical Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Ferrara C; Roche Pharmaceutical Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Brünker P; Roche Pharmaceutical Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Bacac M; Roche Pharmaceutical Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Umana P; Roche Pharmaceutical Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Rüttinger D; Early Clinical Development, Roche Pharmaceutical Research & Early Development, Roche Innovation Center Munich, Penzberg, Switzerland., Wilson IA; ImaginAb Inc., Inglewood, California., Gudas J; ImaginAb Inc., Inglewood, California., Klein C; Roche Pharmaceutical Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Tessier JJL; Early Clinical Development Oncology, Roche Pharmaceutical Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland. jean.tessier@roche.com christoph_michael.griessinger@roche.com.
Publikováno v:
Cancer research [Cancer Res] 2020 Jul 01; Vol. 80 (13), pp. 2903-2913. Date of Electronic Publication: 2020 May 14.
Autor:
Hoffmann SHL; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany., Reck DI; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany., Maurer A; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany.; iFIT-Cluster of Excellence, University of Tübingen, Germany., Fehrenbacher B; Department of Dermatology, Eberhard Karls University Tübingen, Tübingen, Germany., Sceneay JE; Tumor Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia., Poxleitner M; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany., Öz HH; Children's Hospital, University of Tübingen, Tübingen, Germany., Ehrlichmann W; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany., Reischl G; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany.; iFIT-Cluster of Excellence, University of Tübingen, Germany., Fuchs K; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany., Schaller M; Department of Dermatology, Eberhard Karls University Tübingen, Tübingen, Germany., Hartl D; Children's Hospital, University of Tübingen, Tübingen, Germany., Kneilling M; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany.; iFIT-Cluster of Excellence, University of Tübingen, Germany.; Department of Dermatology, Eberhard Karls University Tübingen, Tübingen, Germany., Möller A; Tumor Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia., Pichler BJ; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany.; iFIT-Cluster of Excellence, University of Tübingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tübingen; German Cancer Research Center (DKFZ), Heidelberg, Germany., Griessinger CM; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany.
Publikováno v:
Theranostics [Theranostics] 2019 Aug 12; Vol. 9 (20), pp. 5869-5885. Date of Electronic Publication: 2019 Aug 12 (Print Publication: 2019).
Autor:
Schwenck J; Werner Siemens Imaging Center, Department of Preclinical Imaging and RadiopharmacyEberhard Karls University, 72076 Tübingen, Germany.; Department of Nuclear Medicine and Clinical Molecular Imaging, Eberhard Karls University, 72076 Tübingen, Germany., Maurer A; Werner Siemens Imaging Center, Department of Preclinical Imaging and RadiopharmacyEberhard Karls University, 72076 Tübingen, Germany.; Interfaculty Institute of Biochemistry, Eberhard Karls University, 72076 Tübingen, Germany., Fehrenbacher B; Department of Dermatology, Eberhard Karls University, 72076 Tübingen, Germany., Mehling R; Werner Siemens Imaging Center, Department of Preclinical Imaging and RadiopharmacyEberhard Karls University, 72076 Tübingen, Germany., Knopf P; Werner Siemens Imaging Center, Department of Preclinical Imaging and RadiopharmacyEberhard Karls University, 72076 Tübingen, Germany., Mucha N; Werner Siemens Imaging Center, Department of Preclinical Imaging and RadiopharmacyEberhard Karls University, 72076 Tübingen, Germany., Haupt D; Werner Siemens Imaging Center, Department of Preclinical Imaging and RadiopharmacyEberhard Karls University, 72076 Tübingen, Germany., Fuchs K; Werner Siemens Imaging Center, Department of Preclinical Imaging and RadiopharmacyEberhard Karls University, 72076 Tübingen, Germany., Griessinger CM; Werner Siemens Imaging Center, Department of Preclinical Imaging and RadiopharmacyEberhard Karls University, 72076 Tübingen, Germany., Bukala D; Werner Siemens Imaging Center, Department of Preclinical Imaging and RadiopharmacyEberhard Karls University, 72076 Tübingen, Germany., Holstein J; Department of Dermatology, Eberhard Karls University, 72076 Tübingen, Germany., Schaller M; Department of Dermatology, Eberhard Karls University, 72076 Tübingen, Germany., Menendez IG; Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany., Ghoreschi K; Department of Dermatology, Eberhard Karls University, 72076 Tübingen, Germany.; Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany., Quintanilla-Martinez L; Department of Pathology, Eberhard Karls University, 72076 Tübingen, Germany., Gütschow M; Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn, 53121 Bonn, Germany., Laufer S; Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Eberhard Karls University, 72076 Tübingen, Germany., Reinheckel T; Institute of Molecular Medicine and Cell Research, Medical Faculty, Albert-Ludwigs University, 79085 Freiburg, Germany.; German Cancer Consortium (DKTK), partner site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany., Röcken M; Department of Dermatology, Eberhard Karls University, 72076 Tübingen, Germany., Kalbacher H; Interfaculty Institute of Biochemistry, Eberhard Karls University, 72076 Tübingen, Germany., Pichler BJ; Werner Siemens Imaging Center, Department of Preclinical Imaging and RadiopharmacyEberhard Karls University, 72076 Tübingen, Germany.; German Cancer Consortium (DKTK), partner site Tübingen and German Cancer Research Center (DKFZ), Heidelberg, Germany., Kneilling M; Werner Siemens Imaging Center, Department of Preclinical Imaging and RadiopharmacyEberhard Karls University, 72076 Tübingen, Germany.; Department of Dermatology, Eberhard Karls University, 72076 Tübingen, Germany.
Publikováno v:
Theranostics [Theranostics] 2019 May 31; Vol. 9 (13), pp. 3903-3917. Date of Electronic Publication: 2019 May 31 (Print Publication: 2019).
Autor:
Griessinger CM; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany., Schmid AM; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany., Sonanini D; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany., Schörg BF; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany., Jarboui MA; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany., Bukala D; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany., Mucha N; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany., Fehrenbacher B; Department of Dermatology, Eberhard Karls University Tübingen, Tübingen, Germany., Steinhilber J; Department of Pathology and Neuropathology, Eberhard Karls University Tübingen, Tübingen, Germany.; Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Martella M; Department of Pathology and Neuropathology, Eberhard Karls University Tübingen, Tübingen, Germany.; Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Kohlhofer U; Department of Pathology and Neuropathology, Eberhard Karls University Tübingen, Tübingen, Germany.; Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Schaller M; Department of Dermatology, Eberhard Karls University Tübingen, Tübingen, Germany., Zender L; Department of Internal Medicine VIII, University Hospital Tübingen, Tübingen, Germany.; Department of Physiology I, Institute of Physiology, Eberhard Karls University Tübingen, Tübingen, Germany.; Translational Gastrointestinal Oncology Group, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Rammensee HG; Department of Immunology, Eberhard Karls University, Tübingen, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Partner Site Tübingen, Tübingen, Germany., Quintanilla-Martinez L; Department of Pathology and Neuropathology, Eberhard Karls University Tübingen, Tübingen, Germany.; Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Röcken M; Department of Dermatology, Eberhard Karls University Tübingen, Tübingen, Germany., Kneilling M; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany.; Department of Dermatology, Eberhard Karls University Tübingen, Tübingen, Germany., Pichler BJ; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany.
Publikováno v:
Carcinogenesis [Carcinogenesis] 2019 Apr 29; Vol. 40 (2), pp. 289-302.
Autor:
Sceneay J; Tumor Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia., Griessinger CM; Tumor Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia.; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany., Hoffmann SHL; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany., Wen SW; Tumor Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia., Wong CSF; Tumor Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia., Krumeich S; Tumor Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia., Kneilling M; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany.; Department of Dermatology, Eberhard Karls University Tübingen, Tübingen, Germany., Pichler BJ; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany., Möller A; Tumor Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia.; School of Medicine, University of Queensland, Brisbane, Australia.
Publikováno v:
PloS one [PLoS One] 2018 Apr 20; Vol. 13 (4), pp. e0196040. Date of Electronic Publication: 2018 Apr 20 (Print Publication: 2018).
Autor:
Zeelen C; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Paus C; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Draper D; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Heskamp S; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Signore A; Department of Medical-Surgical Sciences and Translational Medicine, Sapienza University, Rome, Italy.; Department of Nuclear Medicine and Molecular Imaging, Groningen University Medical Center, Groningen, The Netherlands., Galli F; Department of Medical-Surgical Sciences and Translational Medicine, Sapienza University, Rome, Italy., Griessinger CM; Department of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, Tuebingen, Germany., Aarntzen EH; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands - erik.aarntzen@radboudumc.nl.
Publikováno v:
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.. [Q J Nucl Med Mol Imaging] 2018 Mar; Vol. 62 (1), pp. 56-77. Date of Electronic Publication: 2017 Nov 30.